New Preclinical Cryogen-Free 4.7-T MRI System Revealed
By MedImaging International staff writers Posted on 03 Mar 2015 |
Image: MR Solutions’ Cryogen-free 4.7-T MRI Scanner (Photo courtesy of MR Solutions).
A new Magnetic Resonance Imaging (MRI) scanner uses an innovative dry magnet design with low running costs, and a standard low-temperature refrigerator, instead of liquid helium, to cool the magnet to the required 4 K.
The magnetic field strength of the scanner can be adjusted from 0.1– 4.7 T, according to the researcher’s requirements. The new 4.7-T scanner is available with a bore size of 17 cm. The scanner provides high imaging performance with a stray field of only a few centimeters, for placement adjacent to other scanners, and in Class 3 and 4 laboratories. The scanner is intended for soft-tissue contrast, and molecular imaging research.
The 4.7-T scanner is one of a range of scanners developed by MR Solutions (Guildford, Surrey, UK), the world’s largest independent developer and manufacturer of commercially available MRI technology. The scanners are designed to facilitate multimodality imaging, including optical, and Computed Tomography (CT) capabilities. MR Solutions also provides PET-MRI or SPECT-MRI imaging, either for independent, simultaneous, or sequential acquisition. MR Solutions expects that multimodality imaging will become the norm for the study of anatomy, bio-distribution, efficacy, safety and kinetics within the same anatomical context.
CEO of MR Solutions, Dr David Taylor, said: “Although we already had the 3 T and 7 T preclinical MRI systems commercially available, the addition of the new 4.7 T is based upon what our customers are telling us that they want. With this new system customers now have greater flexibility when choosing preclinical MRI multi-modality systems.”
Related Links:
MR Solutions
The magnetic field strength of the scanner can be adjusted from 0.1– 4.7 T, according to the researcher’s requirements. The new 4.7-T scanner is available with a bore size of 17 cm. The scanner provides high imaging performance with a stray field of only a few centimeters, for placement adjacent to other scanners, and in Class 3 and 4 laboratories. The scanner is intended for soft-tissue contrast, and molecular imaging research.
The 4.7-T scanner is one of a range of scanners developed by MR Solutions (Guildford, Surrey, UK), the world’s largest independent developer and manufacturer of commercially available MRI technology. The scanners are designed to facilitate multimodality imaging, including optical, and Computed Tomography (CT) capabilities. MR Solutions also provides PET-MRI or SPECT-MRI imaging, either for independent, simultaneous, or sequential acquisition. MR Solutions expects that multimodality imaging will become the norm for the study of anatomy, bio-distribution, efficacy, safety and kinetics within the same anatomical context.
CEO of MR Solutions, Dr David Taylor, said: “Although we already had the 3 T and 7 T preclinical MRI systems commercially available, the addition of the new 4.7 T is based upon what our customers are telling us that they want. With this new system customers now have greater flexibility when choosing preclinical MRI multi-modality systems.”
Related Links:
MR Solutions
Latest MRI News
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods